Medicare lays out the paperwork it might want to negotiate drug costs

In-depth evaluation of biotech, pharma, and the life sciences

• 

  Award-winning journalism

  from a number of the nation’s most trusted and well-connected reporters within the business

• 

  Weekly stay video chats

  with STAT+ reporters and main business specialists in our STAT+ Conversations sequence

• 

  Unique business occasions

  hosted by STAT+, plus early-bird entry and reductions to business occasions across the nation

• 

  Every day STAT+ newsletters

  get delivered to your inbox to transient you on crucial business information of the day

• 

  Premium knowledge instruments

  like our CRISPR Trackr and Drug Pricing Coverage Tracker